PPD has appointed Darell Heiselman, D.O., to lead cardiovascular and critical care and David Klein, M.D., Ph.D., to oversee endocrinology, metabolism and diabetes. They bring extensive product development and commercialization experience to help clients capitalize on their drug development programs.   “PPD’s global team of scientific, medical and strategic experts provides our clients with expertise that helps reduce the time and cost associated with bringing medicines to market,” said Dr. Rob...